Answers are grounded in this paper and cite their sources.
Although low high-density lipoprotein cholesterol (HDL-C) levels are a common metabolic abnormality associated with insulin resistance, their role in cardiovascular risk stratification remains controversial. Recently, we developed a simple, high-throughput, cell-free assay system to evaluate the "cholesterol uptake capacity (CUC)" as a novel concept for HDL functionality. In this study, we assessed the CUC in patients with hypertriglyceridemia and diabetes mellitus.
No takes yet. Share an insight, caveat, or question.
Seto et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: